These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 13679452)
21. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413 [TBL] [Abstract][Full Text] [Related]
22. p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate. Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; La Manna G; Pinto M; Ciardiello F; La Mura A; De Vita F J Surg Oncol; 2006 Mar; 93(3):241-52. PubMed ID: 16482605 [TBL] [Abstract][Full Text] [Related]
23. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis. Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530 [TBL] [Abstract][Full Text] [Related]
24. Altered expression of key cell cycle regulators in renal cell carcinoma associated with Xp11.2 translocation. Barroca H; Castedo S; Vieira J; Teixeira M; Müller-Höcker J Pathol Res Pract; 2009; 205(7):466-72. PubMed ID: 19246164 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria. Huang HY; Huang WW; Lin CN; Eng HL; Li SH; Li CF; Lu D; Yu SC; Hsiung CY Ann Surg Oncol; 2006 Dec; 13(12):1633-44. PubMed ID: 17013685 [TBL] [Abstract][Full Text] [Related]
26. Correlation of enhanced cell turnover with prognosis of gastrointestinal stromal tumors of the stomach: relevance of cellularity and p27kip1. Nemoto Y; Mikami T; Hana K; Kikuchi S; Kobayashi N; Watanabe M; Okayasu I Pathol Int; 2006 Dec; 56(12):724-31. PubMed ID: 17096729 [TBL] [Abstract][Full Text] [Related]
27. Expression and gene amplification of primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in colon adenocarcinomas and correlation with patient outcome. Bondi J; Husdal A; Bukholm G; Nesland JM; Bakka A; Bukholm IR J Clin Pathol; 2005 May; 58(5):509-14. PubMed ID: 15858123 [TBL] [Abstract][Full Text] [Related]
28. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1). Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203 [TBL] [Abstract][Full Text] [Related]
29. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors. Can B; Sökmensüer C Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191 [TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical analyses of beta-catenin and cyclin D1 expression in giant cell tumor of bone (GCTB): a possible role of Wnt pathway in GCTB tumorigenesis. Matsubayashi S; Nakashima M; Kumagai K; Egashira M; Naruke Y; Kondo H; Hayashi T; Shindo H Pathol Res Pract; 2009; 205(9):626-33. PubMed ID: 19324500 [TBL] [Abstract][Full Text] [Related]
31. Diagnostic and prognostic significance of cyclin A expression in low-grade astrocytomas: comparison with astrogliosis and high-grade tumours. Hara A; Saegusa M; Ichinoe M; Okayasu I J Clin Pathol; 2008 Mar; 61(3):287-92. PubMed ID: 18156430 [TBL] [Abstract][Full Text] [Related]
32. [Expression, localization and interrelationship of P27kip1 and cyclin D3 in non-Hodgkin's lymphoma]. Zhang DM; Lu JX; Shen AG; Chen L; He S; Shao XY; Liu HO; Cheng C Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):723-7. PubMed ID: 16620575 [TBL] [Abstract][Full Text] [Related]
33. Frequency and distribution of trisomy 11 in multiple myeloma patients: relation with overexpression of CCND1 and t(11;14). Guglielmelli T; Giugliano E; Cappia S; Papotti M; Saglio G Cancer Genet Cytogenet; 2007 Feb; 173(1):51-6. PubMed ID: 17284370 [TBL] [Abstract][Full Text] [Related]
34. Protein levels of p21, p27, cyclin E and Bax predict sensitivity to cisplatin and paclitaxel in head and neck squamous cell carcinomas. Taguchi T; Kato Y; Baba Y; Nishimura G; Tanigaki Y; Horiuchi C; Mochimatsu I; Tsukuda M Oncol Rep; 2004 Feb; 11(2):421-6. PubMed ID: 14719078 [TBL] [Abstract][Full Text] [Related]
35. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile. Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770 [TBL] [Abstract][Full Text] [Related]
36. The cyclin-dependent kinase inhibitor, p27, has no correlation with the malignant potential of GIST. Shirin H; Kravtsov V; Shahmurov M; Shabat VS; Krinshpon I; Alin A; Avinoach I; Avni Y Digestion; 2007; 75(1):4-9. PubMed ID: 17406118 [TBL] [Abstract][Full Text] [Related]
37. Mantle cell lymphoma in Taiwan: clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2. Chuang SS; Huang WT; Hsieh PP; Tseng HH; Campo E; Colomer D; Ye H; Lu CL; Chang HM; Cho CY; Huang SH; Lu YC; Wu JD Pathol Int; 2006 Aug; 56(8):440-8. PubMed ID: 16872438 [TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of cell cycle-related molecules in gastric carcinoma: prognostic significance, correlation with clinicopathological parameters, proliferation and apoptosis. Lee KH; Lee HE; Cho SJ; Cho YJ; Lee HS; Kim JH; Nam SY; Chang MS; Kim WH; Lee BL Pathobiology; 2008; 75(6):364-72. PubMed ID: 19096232 [TBL] [Abstract][Full Text] [Related]
39. Cutaneous hidradenocarcinoma: a clinicopathological, immunohistochemical, and molecular biologic study of 14 cases, including Her2/neu gene expression/amplification, TP53 gene mutation analysis, and t(11;19) translocation. Kazakov DV; Ivan D; Kutzner H; Spagnolo DV; Grossmann P; Vanecek T; Sima R; Kacerovska D; Shelekhova KV; Denisjuk N; Hillen U; Kuroda N; Mukensnabl P; Danis D; Michal M Am J Dermatopathol; 2009 May; 31(3):236-47. PubMed ID: 19384064 [TBL] [Abstract][Full Text] [Related]